Home › Core › ISCC-IDs › 28CrVwh189GUw

View ISCC-ID

Core Data

28CrVwh189GUw
ISCC-ID - digital asset identifier
CCd8TGbMD21Ut-CTAUSC97x9VnH-CDLMmH8gTmg4K-CRXpXAnUKJQat
ISCC-CODE - digital asset descriptor
2QTa5N4aeSrCB2MLoPdPF4AsTjstJgcLTnd
PUBLIC-KEY or WALLET-ADDRESS of DECLARING PARTY
0
Number of times updated

Seed Metadata (Immutable)

development of primary malignant melanoma during treatment with a tnfalpha antagonist for severe crohnrsquos disease a case repo

Ledger Reference

coblo
Source Ledger/Blockchain
12374749
N-th ISCC Decleration on source ledger
3eb5acbd89c998b747d01357cfd5f6837920748a55b2ebdf103d4c7e783bfbcf
Hash of block that includes the ISCC-DECLARATION
d2f00662f3b98e6015441472f1d504f6c2a3a6e36d8778c0a3c484113a5e30e8
Hash of transaction that includes the ISCC-DECLERATION
0
Output index that includes ISCC-DECLERATION (UTXO based chains)

Mutable Metadata

[{"data": {"name": "Development of primary malignant melanoma during treatment with a TNF-α antagonist for severe Crohn’s disease: a case report and review of the hypothetical association between TNF-α blockers and cancer", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "Eleni Efremidou", "@type": "Person"}, {"name": "Georgios Kouklakis", "@type": "Person"}, {"name": " Pitiakoudis", "@type": "Person"}, {"name": " Liratzopoulos", "@type": "Person"}, {"name": " Polychronidis", "@type": "Person"}], "license": "cc-by-nc", "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "https://www.dovepress.com/getfile.php?fileID=15601", "encodingFormat": "application/pdf"}], "publisher": {"name": "Informa UK Limited", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.2147/dddt.s41889", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCd8TGbMD21Ut-CTAUSC97x9VnH-CDLMmH8gTmg4K-CRXpXAnUKJQat", "propertyID": "ISCC"}], "datePublished": "2013-03-01"}, "schema": "schema.org", "mediatype": "application/ld+json"}]
Close